A bounded review of one human safety pilot, one literature-and-patent review, and one current human trial protocol.213
Bottom line from this bounded source set
This source set contains a two-person uncontrolled safety pilot, a narrative review dominated by preclinical research, and a recruiting Phase 2 protocol with no posted results. It does not establish human efficacy.213
Reviewed study record
Two-person human safety pilot
Design
An IRB-approved, uncontrolled pilot measured selected laboratory values, vital signs, and participant-reported side effects over a short observation window.2
Population
Two healthy adults at one private clinic participated; both had previously received BPC-157.2
Outcomes reported
The authors reported no measurable changes in the tested biomarkers and no participant-reported side effects during the observation window.2
Limitations
Two previously exposed participants, no comparator, one site, and short follow-up cannot establish general safety or any treatment effect.2
Reviewed study record
Current hamstring-strain protocol
Design
A randomized, parallel, quadruple-masked Phase 2 protocol is listed as recruiting. The registry currently posts a study plan, not results.3
Population
The protocol estimates 120 adults with an acute MRI-confirmed grade II hamstring strain.3
Outcomes reported
Return to unrestricted sport and change in MRI-assessed injury volume are registered primary outcomes; no outcome data are posted.3
Limitations
Recruitment status and planned outcomes do not demonstrate completion, safety, or effectiveness.3
Reviewed study record
Review-level context
Design
A narrative literature-and-patent review summarizes proposed mechanisms, preclinical models, patents, toxicity discussion, and limited clinical context.1
Population
The reviewed activity is primarily drawn from preclinical models rather than controlled human trials.1
Outcomes reported
The review describes favorable findings reported across preclinical models while stating that comprehensive human clinical studies are insufficient.1
Limitations
Narrative synthesis and preclinical findings cannot substitute for controlled human evidence, and the review does not establish clinical benefit.1
No registered Crossref update in the reviewed snapshotChecked August 19, 2026 for DOI 10.3390/ph18020185. This bounded result is not proof that the publication has never been corrected or retracted. Open the pinned Crossref work endpoint ↗